CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2025-08-11 12:02Core Viewpoint - Xiangsheng Medical (688358) has shown a recent stock price increase of 2.85% to 34.6 yuan, with a trading volume of 18,700 hands and a total transaction amount of 64.49 million yuan as of August 11, 2025 [1] Financial Performance - The company reported a main revenue of 128 million yuan in Q1 2025, a year-on-year decrease of 9.16% - The net profit attributable to shareholders was 41.61 million yuan, down 8.62% year-on-year - The net profit after deducting non-recurring gains and losses was 38.87 million yuan, a decline of 13.38% year-on-year - The debt ratio stands at 9.84%, with investment income of 910,800 yuan and financial expenses of -4.76 million yuan - The gross profit margin is 61.33% [2] Market Position - Xiangsheng Medical's total market value is 3.88 billion yuan, compared to the industry average of 11.897 billion yuan, ranking 94th out of 123 in the medical device industry - The company's net assets are 1.462 billion yuan, below the industry average of 3.899 billion yuan, ranking 86th - The net profit of 41.61 million yuan ranks 46th in the industry, with a price-to-earnings ratio of 23.31, significantly lower than the industry average of 68.73, ranking 16th - The price-to-book ratio is 2.87, compared to the industry average of 3.95, ranking 60th - The company's net profit margin is 32.58%, ranking 13th in the industry, while the return on equity (ROE) is 2.89%, ranking 24th [2] Investment Sentiment - In the last 90 days, one institution has given a buy rating for the stock [3]